New research uncovers gut microbiome links to lupus and IBD, pointing to potential biomarkers and personalized treatment options. Study: Lupus and inflammatory bowel disease share a common set of microbiome features distinct from other autoimmune disorders . Image Credit: SewCreamStudio/Shutterstock.
com In a recent study published in Annals of Rheumatic Diseases , researchers identified the microbial profiles linked with autoimmune illnesses, including inflammatory bowel disease (IBD) and systemic lupus erythematosus (SLE). They linked these microbiome patterns to colorectal cancer (CRC) to uncover shared microbial processes and distinct biomarkers. Introduction The gut microbiota is critical in autoimmune illnesses, with some species associated with specific ailments.
Dysbiosis, or severe instability in the gut microbiota, is unique among people, demonstrating a direct relationship between gut composition and clinical symptoms of autoimmune diseases. More extensive studies are required to find biomarkers and understand the processes by which the microbiome impacts autoimmune diseases. Metagenomic investigations provide comprehensive species and functional capabilities that differ between illness states.
However, further study is required to determine the cause and specificity of each condition. About the study The present study used microbiome profiling to discover possible biomarkers and molecular pathways underlying autoimmune disorders, including SLE and IBD. Researchers .